isosorbide dinitrate has been researched along with sildenafil citrate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinsmore, WW; Levi, R; Muirhead, GJ; Sutton, JA; Webb, DJ; Wulff, M | 1 |
| Beppu, S; Hamada, T; Ishikura, F; Khandheria, BK; Nehra, A; Seward, JB | 1 |
| Kingma, JH; Meuleman, EJ | 1 |
| Kloner, RA | 1 |
| Bellamy, GR; Csanady, M; Edes, I; Gillies, H; Jackson, G; Keltai, M; Lisa, L; Widimsky, P | 1 |
| Belardinelli, L; Hintze, TH; Messina, E; Ochoa, M; Serpillon, S; Shryock, J; Xu, X; Zhao, G | 1 |
| Movsesian, MA; Stehlik, J | 1 |
| Dear, JW; Hughes, VE; Oliver, JJ; Webb, DJ | 1 |
| Arsalane, A; Claes, V; Guerin, C; Guizard, M; Hébert, JL; Lecarpentier, E; Lecarpentier, Y; Michel, F; Moumen, A; Timbely, O | 1 |
| Everett, TR; Johal, T; Lees, CC; Wilkinson, IB | 1 |
| Arlt, J; Dahmen, U; Dirsch, O; Homeyer, A; Settmacher, U; Wei, W; Xie, C | 1 |
3 review(s) available for isosorbide dinitrate and sildenafil citrate
| Article | Year |
|---|---|
[Drug treatment of erection disorders in patients with cardiovascular disease].
Topics: Cardiovascular Diseases; Contraindications; Drug Interactions; Erectile Dysfunction; Humans; Isosorbide Dinitrate; Male; Netherlands; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Practice Guidelines as Topic; Purines; Sildenafil Citrate; Sulfones | 2001 |
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents | 2004 |
The nitric oxide pathway and possible therapeutic options in pre-eclampsia.
Topics: Aldehyde Oxidoreductases; Clinical Trials as Topic; Endothelium, Vascular; Female; Humans; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Pre-Eclampsia; Pregnancy; Purines; S-Nitrosothiols; Sildenafil Citrate; Sulfonamides | 2014 |
3 trial(s) available for isosorbide dinitrate and sildenafil citrate
| Article | Year |
|---|---|
Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Aged; Angina Pectoris; Blood Pressure; Contraindications; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2000 |
Hemodynamic effects of sildenafil citrate and isosorbide mononitrate in men with coronary artery disease and erectile dysfunction.
Topics: Adult; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2005 |
Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome | 2010 |
6 other study(ies) available for isosorbide dinitrate and sildenafil citrate
| Article | Year |
|---|---|
Effects of sildenafil citrate (Viagra) combined with nitrate on the heart.
Topics: Administration, Oral; Animals; Blood Flow Velocity; Blood Pressure; Cardiac Output; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Drug Synergism; Heart; Heart Rate; Injections; Isosorbide Dinitrate; Male; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Artery; Purines; Sildenafil Citrate; Stroke Volume; Sulfones; Vasodilator Agents | 2000 |
Nitrates and Viagra can be a deadly combination.
Topics: Coronary Circulation; Drug Synergism; Humans; Hypotension; Isosorbide Dinitrate; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2001 |
Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.
Topics: Acetanilides; Angina Pectoris; Animals; Blood Pressure; Dogs; Enzyme Inhibitors; Heart Rate; Hypotension; Injections, Intravenous; Isosorbide Dinitrate; Male; Piperazines; Purines; Ranolazine; Sildenafil Citrate; Stimulation, Chemical; Sulfones; Vasodilator Agents | 2006 |
Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
Topics: Cyclic GMP; Drug Therapy, Combination; Heart Failure; Humans; Hypertension, Pulmonary; Isosorbide Dinitrate; Male; Middle Aged; Nitro Compounds; Nitroglycerin; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents | 2009 |
Role of both actin-myosin cross bridges and NO-cGMP pathway modulators in the contraction and relaxation of human placental stem villi.
Topics: Actins; Chorionic Villi; Cyclic GMP; Diacetyl; Electric Stimulation; Enzyme Inhibitors; Female; Heterocyclic Compounds, 4 or More Rings; Humans; In Vitro Techniques; Isosorbide Dinitrate; Kinetics; Myosins; Nitric Oxide; Nitric Oxide Donors; Piperazines; Pliability; Potassium Chloride; Pregnancy; Protein Structure, Quaternary; Purines; Second Messenger Systems; Sildenafil Citrate; Sulfones; Term Birth | 2013 |
Modulation of hepatic perfusion did not improve recovery from hepatic outflow obstruction.
Topics: Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Hepatectomy; Isosorbide Dinitrate; Liver; Lypressin; Male; Octreotide; Portal Pressure; Propanolamines; Rats, Inbred Lew; Sildenafil Citrate; Splenectomy; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2017 |